Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Mifepristone by Corcept Therapeutics for Alcohol Dependence: Likelihood of Approval
Mifepristone is under clinical development by Corcept Therapeutics and currently in Phase II for Alcohol Dependence. According to GlobalData, Phase...
Data Insights
Mifepristone by Corcept Therapeutics for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
Mifepristone is under clinical development by Corcept Therapeutics and currently in Phase II for Triple-Negative Breast Cancer (TNBC). According to...